中文簡(jiǎn)介

由Informa Pharmaceutical Science出版(原Ashley Publications)。ISSN: 1471 - 2598。通過(guò)系統(tǒng)的回顧和評(píng)價(jià)，生物治療專(zhuān)家意見(jiàn)涵蓋了生物治療的各個(gè)方面，從治療肽和蛋白質(zhì)到基因轉(zhuǎn)移技術(shù)和藥物傳遞系統(tǒng)，將最新進(jìn)展納入當(dāng)前的治療實(shí)踐，并為未來(lái)的發(fā)展提供專(zhuān)家意見(jiàn)。該領(lǐng)域?qū)⒎譃榱鶄€(gè)主要部分，每個(gè)問(wèn)題將包括:基因治療;疫苗和抗體;交付;細(xì)胞與組織療法;多肽、蛋白質(zhì)和反義;細(xì)胞因子和趨化因子。關(guān)于生物治療的專(zhuān)家意見(jiàn)是同行評(píng)議文章的重要來(lái)源，這些文章關(guān)注的是新興的生物治療藥物和技術(shù)。

投稿網(wǎng)址：https://mc.manuscriptcentral.com/eobt

英文簡(jiǎn)介

Published by Informa Pharmaceutical Science (formerly Ashley Publications). ISSN: 1471-2598.Through systematic review and evaluation, Expert Opinion on Biological Therapy covers all aspects of biological therapy, from therapeutic peptides and proteins to gene transfer technologies and drug delivery systems, placing new advances in the context of current therapeutic practice and providing an expert opinion on the scope for future development. The field will be divided in six major sections, which will be covered in each issue: Gene therapy; Vaccines & antibodies; Delivery; Cell & tissue based therapies; Peptides, proteins & antisense; Cytokines & chemokines. Expert Opinion on Biological Therapy is an essential source of peer-reviewed articles focusing on emerging biotherapeutic drugs and technologies.